Form 4: Cardlytics CFO Sells Shares After RSU Vesting

Cardlytics CFO Alexis DeSieno sold 26,048 shares of common stock at a weighted average price of $1.217 to cover tax obligations following the vesting of 43,750 restricted stock units.

Summary

• Alexis DeSieno, Chief Financial Officer of Cardlytics, Inc. (CDLX), reported transactions related to her beneficial ownership.
• On August 14, 2025, 43,750 restricted stock units (RSUs) vested, converting into common stock.
• On August 15, 2025, 26,048 shares were sold at a weighted average price of $1.217 per share, with prices ranging from $1.19 to $1.265.
• The sale was exclusively conducted to satisfy tax withholding obligations resulting from the RSU vesting.
• Following these transactions, DeSieno's direct beneficial ownership stands at 189,560 shares of common stock.
• The original RSU award was for 350,000 shares, with 50% vesting on August 14, 2024, and the remaining 50% scheduled to vest in equal quarterly amounts over the subsequent one-year period, contingent on continued employment.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a routine RSU vesting and tax-related sale, which is a common occurrence for executives. While it reduces direct ownership, it's not a discretionary sale indicating a lack of confidence. The low sale price is a minor negative, but the nature of the transaction is expected.

Positives

• Vesting of 43,750 restricted stock units indicates continued equity compensation for the Chief Financial Officer.
• The transaction was explicitly stated to be solely for tax withholding purposes, not a discretionary sale by the insider.

Negatives

• A significant number of shares (26,048) were sold, resulting in a reduction of the CFO's direct beneficial ownership.
• The weighted average sale price of $1.217 per share is relatively low.

Risks

• No specific new risks are introduced by this filing beyond the inherent nature of insider transactions and equity compensation structures.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it primarily reports past insider transactions.

Management Comments

• Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on August 14, 2025. The Reporting Person did not sell shares for any other purpose.

Industry Context

This is a routine insider transaction related to equity compensation. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• This filing is a standard Form 4 for insider transactions. The sale of shares to cover tax obligations upon RSU vesting is a common practice across industries for executives receiving equity compensation.
• No specific comparable companies, projects, or results are mentioned in the filing to allow for a detailed comparison of performance or valuation.

Stakeholder Impact

• Shareholders: Minor dilution from RSU vesting, but the sale for tax purposes is a common event and not indicative of a change in company fundamentals.
• Employees: Reinforces the company's use of equity compensation for executives.

Next Steps

• The remaining 50% of the original 350,000 RSU award is scheduled to vest in equal amounts quarterly over the one-year period following August 14, 2024, provided the Reporting Person remains employed by the Issuer on such vesting dates.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving RSU vesting and a subsequent sale of shares solely to cover tax obligations. Such transactions are common for executives receiving equity compensation and do not typically signal a change in the company's fundamental outlook or performance. While the CFO's direct beneficial ownership decreased, it was not a discretionary sale. Therefore, this filing alone does not provide sufficient new information to warrant a change from a 'hold' recommendation, assuming no other significant news or financial performance indicators are present.

Keywords

Cardlytics, CDLX, Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Sale, CFO, Alexis DeSieno, Equity Compensation